Pharma & Biotech

With quarterly results scheduled for release in under one month, Axsome Therapeutics finds itself under investor scrutiny. While the biotechnology...

Iovance Biotherapeutics is embarking on an ambitious worldwide expansion strategy, seeking regulatory clearances for its innovative cancer treatments across multiple...

Eli Lilly finds itself at the heart of a high-stakes legal confrontation that could jeopardize its most profitable revenue stream....

A prolonged regulatory standoff with U.S. health authorities has concluded favorably for Ocugen. The biopharmaceutical company announced that the Food...

Medical technology firm Zynex is confronting a severe strategic crisis, prompting a dramatic shift in direction for its patient monitoring...

Shares of Applied Therapeutics experienced a dramatic upswing on Tuesday, posting an impressive gain of over 11%. The stock reached...

The Danish pharmaceutical leader Novo Nordisk is confronting a perfect storm of adverse developments. A significant legal defeat in the...

Germany's transition to digital prescriptions is proving to be a powerful catalyst for Redcare Pharmacy, with the MDAX-listed company reporting...

The French vaccine developer Valneva finds itself at a pivotal moment, with its future prospects increasingly tied to the success...

Walgreens shareholders are navigating a complex landscape as the pharmacy giant completes its transition to private ownership while confronting substantial...